Old Web
English
Sign In
Acemap
>
authorDetail
>
Ana M Metelo
Ana M Metelo
King's College London
Medicine
Immunology
Multiple myeloma
Anti-BCMA CAR T Cells
Cell therapy
3
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma.
2021
Leukemia
Charlotte Graham
Agnieszka Jozwik
Ruby Quartey-Papafio
Nikolaos Ioannou
Ana M Metelo
Carlo Scala
Glenda Dickson
Orla Stewart
María Almena Carrasco
Elisa Peranzoni
Alan G. Ramsay
Piers E.M. Patten
Thomas Pertel
Farzin Farzaneh
Sandra Dupouy
Andrea Pepper
Reuben Benjamin
Show All
Source
Cite
Save
Citations (1)
Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies
2019
Blood
Charlotte Graham
Agnieszka Jozwik
Ruby Quartey-Papafio
Nikolaos Ioannou
Ana M Metelo
Carlo Scala
Glenda J Dickson
Orla Stewart
María Almena Carrasco
Elisa Peranzoni
Alan G. Ramsay
Sandra Dupouy
Farzin Farzaneh
Piers E.M. Patten
Andrea Pepper
Reuben Benjamin
Show All
Source
Cite
Save
Citations (3)
Allogeneic Anti-Bcma CAR-T Cells Show Tumour Specific Killing Against Primary Multiple Myeloma Cells from Different Genomic Sub-Groups
2019
Blood
Ana M Metelo
Ieuan Walker
Agnieszka Jozwik
Charlotte Graham
Charlotte Attwood
Katy Sanchez
Alan Dunlop
Kirsty Cuthill
Carmel Rice
Matthew Streetly
Trevor Bentley
Bijan Boldajipour
Cesar Sommer
Barbra Johnson Sasu
Reuben Benjamin
Show All
Source
Cite
Save
Citations (2)
1